Abrams DI, Goldman AI, Launer C. et al. A comparative trial of didanosine or zalcitabine after treatment with zidovudine in patients with human immunodeficiency virus infection. New England Journal of Medicine1994; 330: 657-62.
2.
Fleming TR, Sharples K., McCall J. et al. Maintaining confidentiality of interim data to enhance trial integrity and credibility. Clinical Trials2008; 5: 157-67.
3.
Korn EL, Hunsberger S., Freidlin B. et al. Preliminary data release for randomized clinical trials of noninferiority: a new proposal. Journal of Clinical Oncology2005; 23: 5831-36.
Ellenberg SS, Fleming TR, DeMets DLData Monitoring Committees in Clinical Trials: A Practical Perspective. John Wiley & Sons, Chichester, West Sussex, England, 2002.
6.
Lieberman J. , Nauss-Karol C., Salgo M. et al. Safety experience with dideoxycytidine (DDC) in an expanded access population. Int Conf AIDS1992; 8: B87 (abstract no. PoB 3004).
